Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 14 May 2020 |
2 | Reply to Exam Report (MIS-R) | 07 Jul 2020 |
3 | Authorization Letter | 20 Oct 2021 |
3 | Documents in support of Show cause Hearing (SCH) | 20 Oct 2021 |
4 | Authorization Letter | 20 Oct 2021 |
4 | Documents in support of Show cause Hearing (SCH) | 20 Oct 2021 |
5 | Authorization Letter | 22 Dec 2021 |
6 | Authorization Letter | 28 Feb 2022 |
7 | Journal Copy | 25 Jul 2022 |
8 | Certificate | 28 Oct 2022 |
1 | EXAMINATION REPORT | 10123056 | 02 Jul 2020 | |
2 | Hearing Notice (Show Cause) | 11989896 | 12 Aug 2021 | |
3 | Hearing Notice (Show Cause) | 12354815 | 22 Oct 2021 | |
4 | Hearing Notice (Show Cause) | 12728705 | 28 Dec 2021 | |
5 | Hearing Notice (Show Cause) | 13194290 | 16 Mar 2022 | |
6 | Tribunal Accepted Notice for : 4501505 | 13512928 | 5610083 | 19 May 2022 |
The application for Bedapt 350mg was made on 14 May 2020.
The trademark applicant for Bedapt 350mg is BIOLOGICAL E.
Bedapt 350mg is applied in class(es) 5.
Application for Bedapt 350mg is on Registered stage.
Application Id allotted to Bedapt 350mg is 4501505.
Trademark agent or attorney for the application is Kayser And Company.
Bedapt 350mg filed with the Intellectual property office as a WORD.